← FDA DRUG APPROVALS

FDA ANDA · ANDA075528

CLOMID

clomiphene citrate

Sponsor: COSETTE

APPLICATION
ANDA075528
TYPE
ANDA
ORIGINAL APPROVAL
1999-08-30
LATEST ACTION
2026-02-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CLOMIPHENE CITRATEPrescription
CLOMIPHENE CITRATE 50MG · TABLET · ORAL

Approval history

2026-02-24Labeling · Supplement 28 · standardAP
2025-12-18Labeling · Supplement 18 · standardAP
2013-05-23Labeling · Supplement 9 · standardAP
2013-02-19Labeling · Supplement 8 · standardAP
1999-08-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →